Invention Grant
- Patent Title: Mucinous glycoprotein (MUC-1) vaccine
- Patent Title (中): 粘蛋白糖蛋白（MUC-1）疫苗
-
Application No.: US10594992Application Date: 2005-04-01
-
Publication No.: US09173929B2Publication Date: 2015-11-03
- Inventor: B. Michael Longenecker
- Applicant: B. Michael Longenecker
- Applicant Address: US WA Seattle
- Assignee: ONCOTHYREON INC.
- Current Assignee: ONCOTHYREON INC.
- Current Assignee Address: US WA Seattle
- Agency: Wilson Sonsini Goodrich & Rosati
- International Application: PCT/IB2005/002479 WO 20050401
- International Announcement: WO2005/112546 WO 20051201
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K9/127 ; A61K38/17 ; A61K38/20
Abstract:
The present invention provides a method for treating an individual who is afflicted with a cancer, such as non-small cell lung cancer or prostate cancer, by administering to that individual a MUC-1 based formulation. The formulation may be a MUC-1 based liposomal vaccine formulation.
Public/Granted literature
- US20080131495A1 Mucinous Glycoprotein (Muc-1) Vaccine Public/Granted day:2008-06-05
Information query
